EGFR and lung adenocarcinoma: We found that EGFR expression, STAT3, and the thickness of the stratum corneum (both in millimeters and in number of skin layers) had a statistically significant correlation with an adequate response to treatment with EGFR inhibitors in patients with stage IV lung adenocarcinoma.